Introduction
Challenge of airway smooth muscle in vitro with an appropriate antigen provokes the release of a variety of inflammatory mediators. [1] [2] [3] Data obtained in guinea-pig respiratory tissues demonstrated the release of histamine during the contraction induced by antigen as well as metabolites of both the cyclooxygenase and 5-1ipoxygenase pathways. [4] [5] [6] [7] Adams and Lichtenstein showed that human airways when passively sensitized and challenged with ragweed antigen, an initial histamine response followed by a leukotriene (LT) component in the contraction could be observed. Undem et al. described a potential role for products of the cyclooxygenase pathway, specifically PGE2, in regulating histamine release in human bronchial muscles preparations. In addition, these investigators also demonstrated an increased quantity of LTs in the presence of indomethacin (Ind) when human airways were challenged with antigen. In contrast, other authors have shown inhibitory, or no effects, of Ind on antigenic challenge in human airways. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 
Results
Human isolated bronchial muscle preparations contracted when anti-IgE was added to the tissues using either a cumulative or individual dosing method (Fig. 1) . The results obtained using both methods were not significantly different. Anti-IgG did not produce any contraction of preparations (n 3). The effects of the different drugs on the resting tone of human airways are presented in Table   1 and Fig. 2 
